These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32374663)

  • 21. Mortality After Magnetic Resonance Imaging of the Brain in Patients With Cardiovascular Implantable Devices.
    Padmanabhan D; Jondal ML; Hodge DO; Mehta RA; Acker NG; Dalzell CM; Kapa S; Asirvatham SJ; Cha YM; Felmlee JP; Watson RE; Friedman PA
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005480. PubMed ID: 29321191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac implanted electronic devices and MRI safety in 2018-the state of play.
    Shulman RM; Hunt B
    Eur Radiol; 2018 Oct; 28(10):4062-4065. PubMed ID: 29713781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system MRI and cardiac implantable electronic devices.
    Cadieu R; Peron M; Le Ven F; Kerdraon S; Boutet C; Mansourati J; Ben Salem D
    J Neuroradiol; 2017 Feb; 44(1):1-9. PubMed ID: 27814887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiac implantable electronic devices (CIED) not an absolute contraindication to MRI].
    Fahlström M; Subasic I; Teder P; Åberg K; Larsson EM; Blomström-Lundqvist C
    Lakartidningen; 2017 Mar; 114():. PubMed ID: 28350417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Joint Position Paper of the Working Group of Pacing and Electrophysiology of the French Society of Cardiology and the French Society of Diagnostic and Interventional Cardiac and Vascular Imaging on magnetic resonance imaging in patients with cardiac electronic implantable devices.
    Gandjbakhch E; Dacher JN; Taieb J; Chauvin M; Anselme F; Bartoli A; Boyer L; Cassagnes L; Cochet H; Defaye P; Deharo JC; Dubourg B; Fauchier L; Gras D; Klug D; Laurent G; Mansourati J; Marijon E; Maury P; Piot O; Pontana F; Sacher F; Sadoul N; Jacquier A; Boveda S;
    Arch Cardiovasc Dis; 2020; 113(6-7):473-484. PubMed ID: 32473997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices.
    Corzani A; Ziacchi M; Biffi M; Allaria L; Diemberger I; Martignani C; Bratten T; Gardini B; Boriani G
    J Cardiovasc Med (Hagerstown); 2015 Oct; 16(10):704-13. PubMed ID: 26313816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and Quality of 1.5-T MRI in Patients With Conventional and MRI-Conditional Cardiac Implantable Electronic Devices After Implementation of a Standardized Protocol.
    Camacho JC; Moreno CC; Shah AD; Mittal PK; Mengistu A; Lloyd MS; El-Chami MF; Lerakis S; Saindane AM
    AJR Am J Roentgenol; 2016 Sep; 207(3):599-604. PubMed ID: 27304515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
    Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S
    Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How we do it: Cardiac implantable devices are not a contraindication to MRI: time for a paradigm shift.
    De Leon-Benedetti LS; Ramirez-Suarez KI; Otero HJ; Rapp JB; Biko DM; Smith C; Serai SD; Janson C; Shah M; Englehardt G; Fogel M; White AM
    Pediatr Radiol; 2024 May; 54(6):863-875. PubMed ID: 38488925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of radiofrequency on epicardial myocardium after ablation of ventricular arrhythmias from within coronary sinus.
    Candemir B; Ozyurek E; Vurgun K; Turan N; Duzen V; Goksuluk H; Ozyuncu N; Kurklu S; Altin T; Akyurek O; Erol C
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1060-1068. PubMed ID: 29935047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac troponin T in patients with cardiac implantable electronic devices undergoing magnetic resonance imaging.
    Higgins JV; Watson RE; Jaffe AS; Dalzell C; Acker N; Felmlee JP; Asirvatham SJ; Cha YM; Friedman PA; Kapa S
    J Interv Card Electrophysiol; 2016 Jan; 45(1):91-7. PubMed ID: 26489609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safe use of MRI in people with cardiac implantable electronic devices.
    Lowe MD; Plummer CJ; Manisty CH; Linker NJ;
    Heart; 2015 Dec; 101(24):1950-3. PubMed ID: 26420818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society.
    ; Ian Paterson D; White JA; Butler CR; Connelly KA; Guerra PG; Hill MD; James MT; Kirpalani A; Lydell CP; Roifman I; Sarak B; Sterns LD; Verma A; Wan D; ; Crean AM; Grosse-Wortmann L; Hanneman K; Leipsic J; Manlucu J; Nguyen ET; Sandhu RK; Villemaire C; Wald RM; Windram J
    Can J Cardiol; 2021 Jun; 37(6):835-847. PubMed ID: 34154798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of magnetic resonance imaging in patients with legacy pacemakers and defibrillators and abandoned leads.
    Padmanabhan D; Kella DK; Mehta R; Kapa S; Deshmukh A; Mulpuru S; Jaffe AS; Felmlee JP; Jondal ML; Dalzell CM; Asirvatham SJ; Cha YM; Watson RE; Friedman PA
    Heart Rhythm; 2018 Feb; 15(2):228-233. PubMed ID: 29045806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Resonance Imaging in People With Cardiac Implantable Electronic Devices: A Population Based Cohort Study.
    Gillam MH; Inacio MCS; Pratt NL; Shakib S; Roughead EE
    Heart Lung Circ; 2018 Jun; 27(6):748-751. PubMed ID: 29037957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices.
    Bhuva A; Charles-Edwards G; Ashmore J; Lipton A; Benbow M; Grainger D; Lobban T; Gopalan D; Slade A; Roditi G; Manisty C
    Heart; 2024 Jan; 110(4):e3. PubMed ID: 36104218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI safety management in patients with cardiac implantable electronic devices: Utilizing failure mode and effects analysis for risk optimization.
    Ryan JW; Murray AS; Gilligan PJ; Bisset JM; Nolan C; Doyle A; Emerson B; Galvin JM; Murray JG
    Int J Qual Health Care; 2020 Sep; 32(7):431-437. PubMed ID: 32578847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wideband LGE MRI permits unobstructed viewing of myocardial scarring in a patient with an MR-conditional subcutaneous implantable cardioverter-defibrillator.
    Rahsepar AA; Collins JD; Knight BP; Hong K; Carr JC; Kim D
    Clin Imaging; 2018; 50():294-296. PubMed ID: 29747127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI-Guided ventricular tachycardia ablation: integration of late gadolinium-enhanced 3D scar in patients with implantable cardioverter-defibrillators.
    Dickfeld T; Tian J; Ahmad G; Jimenez A; Turgeman A; Kuk R; Peters M; Saliaris A; Saba M; Shorofsky S; Jeudy J
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):172-84. PubMed ID: 21270103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac CT With Delayed Enhancement in the Characterization of Ventricular Tachycardia Structural Substrate: Relationship Between CT-Segmented Scar and Electro-Anatomic Mapping.
    Esposito A; Palmisano A; Antunes S; Maccabelli G; Colantoni C; Rancoita PMV; Baratto F; Di Serio C; Rizzo G; De Cobelli F; Della Bella P; Del Maschio A
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):822-832. PubMed ID: 26897692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.